Ropeginterferon dose-escalation strategies in polycythemia vera: a systematic review and meta-analysis
Abstract Background Ropeginterferon alfa-2b is increasingly used as a long-acting interferon therapy for polycythemia vera (PV), providing hematologic and molecular benefits. However, clinical studies have implemented different dose-escalation strategies, and their impact on outcomes has not been sy...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2026-04-01
|
| Serier: | BMC Cancer |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s12885-026-15939-x |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
